Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04179864
Title A Phase 1b/2 Open-Label Study in Chemotherapy Naive Subjects With Metastatic Castration-Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Epizyme, Inc.
Indications

prostate small cell carcinoma

prostate neuroendocrine neoplasm

prostate adenocarcinoma

Therapies

Enzalutamide + Tazemetostat

Abiraterone + Prednisone + Tazemetostat

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.